Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Ciobanu, V. Maciuc, G. Tofan, L. Popa (Iasi, Romania). Is there a strong relationship between COPD and cardiovascular diseases?. Eur Respir J 2013; 42: Suppl. 57, 3743

Member's Comments

No comment yet.

Related content which might interest you: Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Comparison of comorbidities between two different subgroups in combined assessment of COPD Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease Year: 2016 Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype Source: Annual Congress 2013 –COPD treatment Year: 2013 How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients? Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Prevalence of COPD in vascular diseases Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Falls, an underestimated risk in COPD Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Is COPD an independent predictor of osteoporosis? Source: International Congress 2015 – COPD: notable points Year: 2015 Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Effect of systemic inflammation and multi-morbidity on outcome of adult-onset asthma Source: International Congress 2016 – Asthma management Year: 2016 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 Correlation between red cell distribution width and disease severity and mortality in COPD patients Source: International Congress 2014 – COPD exacerbations Year: 2014 The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013